Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-29
1996-05-21
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514293, 544369, 546 83, 548166, 548183, 548186, 548188, C07D27736, A01K 31425
Patent
active
055190405
ABSTRACT:
The present invention provides novel carbonic anhydrase inhibitors represented by the structural formula: ##STR1## wherein
REFERENCES:
patent: 2994701 (1961-08-01), Sprague
patent: 4386098 (1983-05-01), Woltersdorf, Jr. et al.
patent: 4416890 (1983-11-01), Woltersdorf, Jr.
patent: 4426388 (1984-01-01), Woltersdorf, Jr.
patent: 4477466 (1984-10-01), Shepard
patent: 4486444 (1984-12-01), Shepard
patent: 4542152 (1985-09-01), Shepard
patent: 4544667 (1985-10-01), Shepard et al.
patent: 5300499 (1994-04-01), Chow
Journal Of The American Chemical Society, vol. 72, No. 11, 17 Nov. 1950, pp. 4893-4896, W. Miller, "Heterocyclic sulfonamides as carbonic anhydrase inhibitors".
Journal Of Heterocyclic Chemistry, vol. 18, No. 5, Aug. 1981, pp. 997-1006, Cremlyn et al, "Some heterocyclic sulfonyl chlorides and derivatives".
Chow Ken
Garst Michael E.
Holmes Judith M.
Allergan
Baran Robert J.
Gerstl Robert
Hoch James M.
Voet Martin A.
LandOfFree
Substituted thiazole sulfonamides as antiglaucoma agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted thiazole sulfonamides as antiglaucoma agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted thiazole sulfonamides as antiglaucoma agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2038352